Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Primary Surgical Therapy for Biologically Defined Low-Risk Neuroblastoma: A Pediatric Oncology Group/Children's Cancer Group Intergroup Study

NCT00003119 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT00003119
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00003119 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Primary Surgical Therapy for Biologically Defined Low-Risk Neuroblastoma: A Pediatric Oncology Group/Children's Cancer Group Intergroup Study
Lead sponsor
Children's Oncology Group
Phase
Phase 3
Overall status
Completed
Start date
March 31, 1998
Completion date
March 31, 2006
Enrollment
968 (actual)
Sites
235

Conditions

As the registry lists them; a condition with its own page is linked.

neuroblastoma